Press release
Chronic Cough Market Demonstrates Long-Term Growth Potential At 9.9% CAGR
Chronic Cough Market
Projected Growth Outlook for the Chronic Cough Market Through 2030
The chronic cough market is expected to experience robust growth, reaching a valuation of $14.17 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 9.9% throughout the forecast period. Several factors contribute to this upward trend, including an increased focus on personalized respiratory care, rising funding in innovative cough treatments, growing preference for non-opioid cough suppressants, wider adoption of telehealth services for respiratory conditions, and a stronger emphasis on managing symptoms over the long term. Key trends influencing market development include advancements in targeted antitussive therapies, growing interest in combination drug formulations, rising use of long-acting cough suppressants, expansion of treatments addressing acid reflux-induced cough, and improved methods for differential diagnosis.
The chronic cough market size has grown strongly in recent years. It will grow from $8.87 billion in 2025 to $9.71 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to rising prevalence of asthma and allergies, increased awareness of chronic respiratory conditions, wider availability of over-the-counter cough medications, improved diagnostic capabilities for respiratory disorders, expansion of outpatient respiratory care.
Download a free sample of the chronic cough market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12109&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Top Companies Driving the Chronic Cough Market
A range of prominent pharmaceutical and healthcare companies are actively shaping the chronic cough market. Leading players include Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca plc, GlaxoSmithKline Plc, Merck KGaA, Reckitt Benckiser Group plc, Glenmark Pharmaceuticals Ltd, Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals Plc, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., and NeRRe Therapeutics Ltd.
One notable industry move occurred in June 2023, when UK-based global healthcare firm GSK Plc. completed the acquisition of BELLUS Health for an undisclosed amount. This acquisition strengthens GSK's portfolio in rare diseases, accelerates the development and commercialization of cutting-edge therapies, and expands its footprint in the specialty pharmaceuticals arena. BELLUS Health, headquartered in Canada, is a clinical-stage biopharmaceutical company focused on chronic cough treatments.
View the full chronic cough market report:
https://www.thebusinessresearchcompany.com/report/chronic-cough-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Aug_PR
Positive Market Trends Accelerating Growth in Chronic Cough
The chronic cough market is also witnessing a surge in innovation, particularly in the development of biosimilars, which are gaining traction as cost-effective alternatives to original biologic drugs. Biosimilars are widely used in treating diseases such as cancer, autoimmune conditions, and diabetes, thereby supporting market growth through affordable treatment options. For example, in July 2024, Swiss pharmaceutical company Sandoz launched its biosimilar Pyzchiva (ustekinumab) across European markets. This product targets chronic inflammatory diseases including plaque psoriasis, psoriatic arthritis, and Crohn's disease. Pyzchiva is notable for being the first biosimilar in Europe to offer all reference medicine strengths, including the initial dose required for Crohn's disease treatment. Developed in partnership with Samsung Bioepis, this launch demonstrates Sandoz's commitment to improving healthcare accessibility and patient outcomes across Europe.
Detailed Segmentation of the Chronic Cough Market
This analysis segments the chronic cough market into specific categories for a detailed understanding:
1) Drug Class: Antihistamines, Corticosteroids, Decongestants, Combination Drugs, Antibiotics, Acid Blockers, and Other Drug Classes
2) Route of Administration: Oral, Inhalational, Injectable, and Other Methods
3) Distribution Channel: Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies
4) End-Users: Hospitals, Homecare Settings, Specialty Centers, and Other End Users
Further subcategories include:
- Antihistamines split into First-Generation and Second-Generation
- Corticosteroids divided into Inhaled and Systemic types
- Decongestants categorized as Oral or Nasal
- Combination Drugs such as Antihistamine and Decongestant blends and Cough Suppressant and Expectorant mixes
- Antibiotics covering Macrolides, Penicillins, and Cephalosporins
- Acid Blockers including Proton Pump Inhibitors (PPIs) and H2-Receptor Antagonists
- Other Drug Classes consisting of Mucolytics, Cough Suppressants, and Herbal Remedies
Together, these segments provide a comprehensive framework for understanding the market's structure and identifying growth opportunities.
Our 2026 market reports now offer broader strategic coverage through market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Cough Market Demonstrates Long-Term Growth Potential At 9.9% CAGR here
News-ID: 4606119 • Views: …
More Releases from The Business Research Company
Chronic Pain Market Outlook Highlights Strategic Opportunities Across The Indust …
The chronic pain market is on track for significant expansion in the coming years, driven by advances in treatment options and evolving healthcare delivery models. As demand grows for more personalized and effective pain management strategies, this sector is expected to witness considerable development through 2030. Let's explore the market's projected growth, key players, emerging trends, and important segments shaping its future.
Chronic Pain Market Size and Forecast Through 2030 …
Chronic Lower Back Pain Market Study Explores Industry Growth Toward $10.05 Bill …
Understanding the chronic lower back pain market reveals promising growth prospects driven by technological innovations and evolving treatment approaches. This sector is witnessing significant advancements aimed at addressing the complex needs of patients suffering from persistent back pain, with new therapies and personalized care strategies shaping its future landscape.
Projected Value and Expansion Rates in the Chronic Lower Back Pain Market
The chronic lower back pain market is set to…
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Research Reveals …
The chronic inflammatory demyelinating polyneuropathy (CIDP) market is poised for significant expansion in the coming years, driven by advancements in treatment and growing patient awareness. As the medical community continues to innovate, the market outlook suggests promising opportunities for enhanced therapies and improved patient care.
Anticipated Market Growth and Size of the CIDP Market
The CIDP market is projected to reach a value of $3.32 billion by 2030, growing at…
Choroidal Neovascularization Market Outlook Signals Expansion To $5.98 Billion T …
The choroidal neovascularization market is on track for considerable expansion as we approach 2030. Advances in treatment options and rising awareness of eye health are setting the stage for strong growth in this specialized ophthalmic sector. Let us explore the projected market size, key players, emerging trends, and detailed segment insights shaping this industry.
Forecasted Growth and Market Size of the Choroidal Neovascularization Market
The global choroidal neovascularization market is…
More Releases for Cough
Dog's Cough Intensifies Due to Temperature Difference, Trusted Dog Cough Medicin …
Image: https://www.getnews.info/uploads/e50cc9d317e270f5e3e669a0339f0b84.jpg
During periods of significant temperature fluctuations, not only humans but also many dogs are prone to experiencing coughing symptoms. Differences between daytime and nighttime temperatures, dry weather, and frequent transitions between indoor and outdoor environments can directly affect the bronchial health of dogs, making them more susceptible to respiratory problems. In particular, sudden changes in weather can make a dog's respiratory system sensitive, resulting in noticeable coughing symptoms.
Coughing in…
Cough Care Advance launches Cough Care Advance, an innovative, kid-friendly coug …
Cough Care Advance is introducing an innovative, kid-friendly cough remedy that provides safe, natural, and long-lasting relief.
Parents know how difficult it can be when children are battling a stubborn cough. Whether it's keeping them up at night or disrupting their day at school, finding an effective and gentle solution is a top priority. That's why Cough Care Advance is introducing an innovative, kid-friendly cough remedy that provides safe, natural, and…
Refractory Chronic Cough Therapeutics Market - Silencing the Cough: Innovative T …
Newark, New Castle, USA: The "Refractory Chronic Cough Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Refractory Chronic Cough Therapeutics Market: https://www.growthplusreports.com/report/refractory-chronic-cough-therapeutics-market/7991
This latest report researches the…
Refractory Chronic Cough Therapeutics Market - Pioneering Solutions for Persiste …
Newark, New Castle, USA - new report, titled Refractory Chronic Cough Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Refractory Chronic Cough Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Refractory Chronic Cough Therapeutics market. The report offers…
Cough Systems Market
Global cough systems market size is expected to be worth roughly USD 192.8 million by 2030, growing at a CAGR of more than 8.6% during the projected timeframe of 2022-2030, according to Ameco Research
Cough systems are appliances that assist to cleanse the lungs of excessive cough output by changing the flow patterns, which enhances the airway patency and helps to establish and promote alveolar growth. Excessive coughing produces severe lung…
Global Cough Syrup Market Size, Cough Syrup Market Share, Cough Syrup Market Gro …
The Global "Cough Syrup Market" 2022 research report presents an in-depth analysis of the Cough Syrup Market size, growth, share, segments, manufacturers, and forecast, competition landscape and growth opportunity. The research's goal is to provide market data and strategic insights to help decision-makers to make educated investment decisions while also identifying potential gaps and development possibilities.We also analysed the impact of COVID-19 (Corona Virus) on the product industry chain based…
